U.S. Insomnia Therapies Markets
U.S. Insomnia Therapies Markets
RELEASE DATE
16-Apr-2004
16-Apr-2004
REGION
North America
North America
Research Code: A747-01-00-00-00
SKU: HC00961-NA-MR_04816
$2,450.00
Special Price $1,837.50 save 25 %
In stock
SKU
HC00961-NA-MR_04816
Description
This research service analyzes the changing dynamics within the U.S. insomnia therapies market. Included in this research service are revenue forecasts, market shares, patient forecasts, market and technology trends, factors affecting market growth, major issues and challenges, pricing trends, and product analysis. The market is segmented by product class - benzodiazepines, sedating antidepressants, non-benzodiazepines, and emerging therapies. This research service discusses the current and future market landscape, critically evaluates each major product, and highlights the window of opportunities in this fledgling market.
Table of Contents
Executive Summary
- Executive Summary
Overview
- Scope and Segmentation
- Research Methodology
- Introduction
- Market and Technology Trends
Market Dynamics
- Demand Analysis
- Patient Forecasts
- Revenue Forecasts
- Industry Issues and Challenges
Competitive Landscape
- Competitive Structure
- Pipeline Analysis
- Market Share Analysis
Frost & Sullivan Awards
- Product Value Enhancement of the Year Award
- Specialty Product of the Year Award
- Industry Innovation and Advancement of the Year Award
- Company of the Year Award
Segment Highlights
Overview
Market Forecasts and Trends
Competitive Analysis
- Segment Highlights
Segment Highlights
Overview
Market Forecasts and Trends
Competitive Analysis
Segment Highlights
Overview
Market Forecasts and Trends
Competitive Analysis
Segment Highlights
Overview
Market Forecasts and Trends
Decision Support Database
Popular Topics
This research service analyzes the changing dynamics within the U.S. insomnia therapies market. Included in this research service are revenue forecasts, market shares, patient forecasts, market and technology trends, factors affecting market growth, major issues and challenges, pricing trends, and product analysis. The market is segmented by product class - benzodiazepines, sedating antidepressants, non-benzodiazepines, and emerging therapies. This research service discusses the current and future market landscape, critically evaluates each major product, and highlights the window of opportunities in this fledgling market.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | A747-01-00-00-00 |
Is Prebook | No |